Pharmaceuticals (147) | Registration Rights Agreements (147)

Browse by Company

Recent Contracts

Third Amended and Restated Registration Rights Agreement, dated as of May 1, 2021, by and among Roivant Sciences Ltd. and the parties thereto (Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
Registration Rights Agreement, by and between the Company and Dutchess Capital Growth Fund LP, dated May 31, 2022 (Marijuana Co of America, Inc., Filed With SEC on June 3, 2022)
Form of Registration Rights Agreement (Biofrontera Inc., Filed With SEC on May 20, 2022)
Registration Rights Agreement between Artelo Biosciences, Inc. and Lincoln Park Capital Fund, LLC, dated May 13, 2022 (ARTELO BIOSCIENCES, INC., Filed With SEC on May 16, 2022)
Form of Registration Rights Agreement dated April 20, 2022 between the Company and the Purchaser (Dermata Therapeutics, Inc., Filed With SEC on April 25, 2022)
Piggy-back Registration Rights Agreement dated April 14, 2022 between RespireRx Pharmaceuticals Inc. and Barton Asset Management LLC (RespireRx Pharmaceuticals Inc., Filed With SEC on April 15, 2022)
Registration Rights Agreement, dated as of April 7, 2022, by and among Lyra Therapeutics, Inc. and the Investors named therein (Lyra Therapeutics, Inc., Filed With SEC on April 13, 2022)
Registration Rights Agreement, dated as of April 12, 2022, by and between the Company and Lincoln Park (Aquestive Therapeutics, Inc., Filed With SEC on April 13, 2022)
Registration Rights Agreement, effective as of August 3, 2021 (Rani Therapeutics Holdings, Inc., Filed With SEC on March 31, 2022)
Registration Rights Agreement, dated March 23, 2022, by and between Processa Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (Processa Pharmaceuticals, Inc., Filed With SEC on March 24, 2022)